Product Code: ETC206081 | Publication Date: May 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 40 | No. of Tables: 7 | |
The Philippines Isosorbide Mononitrate market size was valued at US$ 1.4 million in 2025 and is expected to witness significant growth over the forecast period. Isosorbide mononitrate is majorly used by patients suffering from angina pectoris or unstable angina due to its ability to increase nitric oxide levels which helps reduce chest pain associated with coronary artery disease conditions or myocardial infarction caused due to insufficient blood flow towards heart muscles. Furthermore, it also plays an important role in treating congestive heart failure by reducing preload on left ventricular. This factor coupled with increasing prevalence of cardiogenic diseases will propel market growth over coming years.
The Philippines Isosorbide Mononitrate market has experienced steady growth due to its application in the pharmaceutical industry. Isosorbide Mononitrate is primarily used to treat angina and heart-related conditions. The rising prevalence of cardiovascular diseases and the increasing awareness of the importance of heart health are driving the demand for this compound in the country. Additionally, advancements in healthcare infrastructure and the availability of generic versions of Isosorbide Mononitrate have further contributed to market growth.
The Philippines Isosorbide Mononitrate market faces several challenges. Regulatory hurdles, including the need for stringent approvals from healthcare authorities, can slow down the introduction of new products. Additionally, market competition and pricing pressures can impact the profitability of manufacturers. Ensuring a consistent and high-quality supply while adhering to international standards is crucial for sustained growth in this market.
The Philippines Isosorbide Mononitrate market has experienced fluctuations due to various factors, including changes in healthcare priorities and demand for cardiovascular medications. The COVID-19 pandemic disrupted healthcare systems and diverted resources towards managing the virus, affecting the market dynamics. However, as the country gradually recovers from the pandemic, the Isosorbide Mononitrate market is expected to stabilize.
The key players operating in the Philippines Isosorbide Mononitrate Market include Pfizer Inc., Merck & Co., Inc., Sanofi Aventis S.A., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Ltd., Dr Reddy`s Laboratories Ltd, Apotex Corporation and Perrigo Company plc.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Isosorbide Mononitrate Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Isosorbide Mononitrate Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Isosorbide Mononitrate Market - Industry Life Cycle |
3.4 Philippines Isosorbide Mononitrate Market - Porter's Five Forces |
3.5 Philippines Isosorbide Mononitrate Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Philippines Isosorbide Mononitrate Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Philippines Isosorbide Mononitrate Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in the Philippines |
4.2.2 Growing awareness about the benefits of isosorbide mononitrate in treating heart conditions |
4.2.3 Rise in healthcare expenditure and improving healthcare infrastructure in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for pharmaceutical products |
4.3.2 Presence of alternative treatment options for cardiovascular diseases |
4.3.3 Price fluctuations in raw materials used for manufacturing isosorbide mononitrate |
5 Philippines Isosorbide Mononitrate Market Trends |
6 Philippines Isosorbide Mononitrate Market, By Types |
6.1 Philippines Isosorbide Mononitrate Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Isosorbide Mononitrate Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 Philippines Isosorbide Mononitrate Market Revenues & Volume, By 10 mg Tablet, 2021-2031F |
6.1.4 Philippines Isosorbide Mononitrate Market Revenues & Volume, By 20 mg Tablet, 2021-2031F |
6.2 Philippines Isosorbide Mononitrate Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Philippines Isosorbide Mononitrate Market Revenues & Volume, By Treatment of angina pectoris, 2021-2031F |
6.2.3 Philippines Isosorbide Mononitrate Market Revenues & Volume, By Others, 2021-2031F |
7 Philippines Isosorbide Mononitrate Market Import-Export Trade Statistics |
7.1 Philippines Isosorbide Mononitrate Market Export to Major Countries |
7.2 Philippines Isosorbide Mononitrate Market Imports from Major Countries |
8 Philippines Isosorbide Mononitrate Market Key Performance Indicators |
8.1 Number of prescriptions for isosorbide mononitrate by healthcare providers |
8.2 Patient adherence rate to isosorbide mononitrate treatment |
8.3 Number of clinical trials and studies supporting the efficacy of isosorbide mononitrate |
8.4 Average length of hospital stay for patients using isosorbide mononitrate |
8.5 Rate of adverse events reported related to isosorbide mononitrate |
9 Philippines Isosorbide Mononitrate Market - Opportunity Assessment |
9.1 Philippines Isosorbide Mononitrate Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Philippines Isosorbide Mononitrate Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Philippines Isosorbide Mononitrate Market - Competitive Landscape |
10.1 Philippines Isosorbide Mononitrate Market Revenue Share, By Companies, 2024 |
10.2 Philippines Isosorbide Mononitrate Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |